Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Case Report

Familial Lassueur-Graham-Little-Piccardi Syndrome

Viglizzo G. · Verrini A. · Rongioletti F.

Author affiliations

Department of Endocrinologic and Metabolic Diseases, Section of Dermatology, University of Genoa, Genoa, Italy

Related Articles for ""

Dermatology 2004;208:142–144

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: June 10, 2003
Accepted: September 24, 2003
Published online: March 29, 2004
Issue release date: July 2004

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 1

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM

Abstract

Lassueur-Graham-Little-Piccardi syndrome (LGLPS) is a rare lichenoid dermatosis characterized by progressive cicatricial alopecia of the scalp, loss of pubic and axillary hairs and keratosis pilaris. The syndrome is considered a form of follicular lichen planus (LP). Although the familial occurrence of LP is a well-described phenomenon, no familial case of LGLPS has ever been reported. We describe the occurrence of LGLPS in a mother and her daughter. HLA typing revealed HLA-DR1 in both patients. Topical tacrolimus was of partial benefit in the daughter.

© 2004 S. Karger AG, Basel


References

  1. Dawber RPR, de Berker D, Wojnarowska F: Disorders of hair; in Champion RH, Burton JL, Burs DA, Breathnach SM (eds): Textbook of Dermatology, ed 6. Oxford, Blackwell Science Ltd, 1998, vol 4, p 2935.
  2. Waldorf DS: Lichen planopilaris. Arch Dermatol 1966;93:684–689.
  3. Kofoed ML, Wantzin GL: Familial lichen planus. J Am Acad Dermatol 1985;13:50–54.
  4. Pages F, Lapyre J, Misson R: Syndrome de Lassueur-Graham-Little. Ann Dermatol 1961;88:272–280.
  5. Amato L, Mei S, Massi D, Gallerani I, Fabbri P: Cicatricial alopecia: A dermatopathologic and immunopathologic study of 33 patients. Int J Dermatol 2002;41:8–15.
  6. Kunte C, Loeser C, Wolff H: Folliculitis spinulosa decalvans: Successful therapy with dapsone. J Am Acad Dermatol 1998;39:891–893.
  7. Bardazzi F, Landi C, Orlandi C: Graham-Little-Piccardi-Lassueur syndrome following HBV vaccination. Acta Derm Venereol 1999;79:93.
  8. Rebora A, Rongioletti F, Drago F, Parodi A: Lichen planus as a side effect of HBV vaccination. Dermatology 1999;198:1–2.
  9. Katzenelson V, Lotem M, Sandbank M: Familial lichen planus. Dermatologica 1990;180:166–168.
  10. Fernandez Rodriguez JC, Pinto Soares A, Garcia Silva L: Follicular psoriasis with cicatricial alopecia: Piccardi-Lassueur-Graham-Little syndrome of a psoriatic nature. Med Cutan Ibero Lat Am 1983;11:687–694.
  11. Crickx B, Blanchet P, Grossin M, Belaich S: Lassueur-Graham-Little syndrome: Two cases. Ann Dermatol Vénéréol 1990;117:907–909.
  12. Bianchi L, Paro Vidolin A, Piemonte P, Carboni I, Chimenti S: Graham-Little-Piccardi-Lassueur syndrome: Effective treatment with cyclosporin A. Clin Exp Dermatol 2001;26:518–520.
    External Resources
  13. George SJ, Hsu S: Lichen planopilaris treated with thalidomide. J Am Acad Dermatol 2001;45:965–966.
  14. Kaliakatsu F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR: Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35–41.

Article / Publication Details

First-Page Preview
Abstract of Case Report

Received: June 10, 2003
Accepted: September 24, 2003
Published online: March 29, 2004
Issue release date: July 2004

Number of Print Pages: 3
Number of Figures: 4
Number of Tables: 1

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.